A study has found that leukaemia cell lines and primary acute myeloid leukaemia (AML/LAML) samples have an increased dependence on UBA1 and a decreased enzyme reserve capacity, indicating that inhibiting UBA1 may be valuable in the treatment of AML.10 Here, UBA1 is linked to leukemia.